
Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-11-19 15:01:18Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential shifts in investor positioning. Despite trading within a narrow price range and underperforming its sector marginally, the stock’s derivatives activity suggests heightened directional bets as it nears its 52-week high.
Read MoreMankind Pharma Gains 4.49%: 3 Key Factors Driving the Week’s Momentum
2026-11-14 11:00:37Key Events This Week Nov 09: New 52-week high (Rs.2,685) Nov 09: Surge in call option activity Nov 09: Sharp open interest increase in derivatives Nov 12: Technical momentum shifts amid mixed signals Nov 13: Week closes at Rs.2,654 (+4.49%) Week OpenRs.2,540.00 Week Close<di...
Read More
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-11-09 15:00:16Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock recently hit a new 52-week high of Rs 2,663, supported by strong volume and positive price action, reflecting growing investor confidence in this mid-cap pharmaceutical player.
Read More
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-11-09 14:00:15Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and potential directional bets. The stock’s recent price action, combined with robust volume and improving mojo scores, suggests growing investor confidence in the pharmaceuticals & biotechnology sector.
Read More
Mankind Pharma Ltd Sees Sharp Open Interest Surge Signalling Bullish Market Positioning
2026-11-09 13:00:11Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock, trading close to its 52-week high, has outperformed its sector and demonstrated robust volume and price action, reflecting growing investor confidence in the pharmaceuticals and biotechnology space.
Read More
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-11-09 12:00:11Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock recently hit a new 52-week high of Rs 2,644.4, supported by robust volume and positive price action, reflecting growing investor confidence in the mid-cap pharmaceutical player.
Read More
Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Bullish Market Momentum
2026-11-09 11:00:12Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved mojo ratings, suggests growing investor confidence in this mid-cap pharmaceutical player.
Read More
11,607 Call Contracts Traded on Mankind Pharma Ltd as Stock Rallies 6.5% in Three-Day Streak
2026-11-09 11:00:1111,607 call contracts on Mankind Pharma Ltd changed hands on 09 Nov 2026, coinciding with a 3.18% gain in the stock price to close at Rs 2,662.70. The options activity clustered around the Rs 2,700 strike price, just slightly out-of-the-money relative to the underlying, signalling a speculative but near-term directional bet.
Read More
Mankind Pharma Ltd Sees Significant Open Interest Surge Amid Bullish Momentum
2026-11-09 10:00:07Mankind Pharma Ltd (MANKIND) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price action, coupled with increased volumes and a notable upgrade in its Mojo Grade to Buy, underscores growing investor confidence in this mid-cap pharmaceutical player.
Read MoreAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
19-Nov-2026 | Source : BSEPlease find attached intimation regarding allotment of 38442 equity shares pursuant to ESOP Plan
Change In Corporate Office Address Of RTA
13-Nov-2026 | Source : BSEPlease find attached intimation regarding change in Corporate Office Address of RTA
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Nov-2026 | Source : BSEPlease find attached Intimation of participation in the Investor Conference
Corporate Actions
No Upcoming Board Meetings
Mankind Pharma Ltd has declared 100% dividend, ex-date: 08 Aug 25
No Splits history available
No Bonus history available
No Rights history available